Differential Hypoxemia During Veno‐Arterial Extracorporeal Organ Support: Its Impact on Mortality and Different Treatment Strategies
Development of differential hypoxemia is associated with significantly increased mortality rates among ECLS patients and should therefore be prevented as far as possible. Non-invasive administration of beta-blockers seems to be the more effective treatment option for differential hypoxemia, as the introduction of a second arterial ECLS cannula was a risk factor for mortality.
Authors
- Anneke Neumann (ORCID: https://orcid.org/0000-0001-8524-6699)
- Rafal Berger (ORCID: https://orcid.org/0000-0002-8245-4457)
- Lina María Serna-Higuita (ORCID: https://orcid.org/0000-0001-5182-8295)
- Metesh Acharya (ORCID: https://orcid.org/0000-0003-1744-7717)
- Aron‐Frederik Popov (ORCID: https://orcid.org/0000-0003-4226-3004)
- Jana Buob
Institutions
- Zimmer Biomet (Netherlands) (NL)
- Glenfield Hospital (GB)
- Asklepios Klinikum Harburg (DE)
- Klinikum Ludwigsburg (DE)
- University of Tübingen (DE)
Publication Details
- Journal
- Artificial Organs
- Published
- 2025-10-09
- DOI
- https://doi.org/10.1111/aor.70016
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 0.00